Cargando…

Gabapentinoids for Pruritus in Older Adults: A Narrative Review

There is currently no standardized algorithm for the treatment of chronic pruritus (CP), or itch lasting more than 6 weeks, in adults aged ≥ 65 years. The antiepileptic agents gabapentin and pregabalin, however, are gaining popularity in the dermatologic community for their efficacy in treating CP o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sreekantaswamy, Shreya A., Mollanazar, Nicholas, Butler, Daniel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163906/ https://www.ncbi.nlm.nih.gov/pubmed/33721214 http://dx.doi.org/10.1007/s13555-021-00513-z

Ejemplares similares

Reframing aging in dermatology: The role of the dermatologist in healthy aging
por: Sreekantaswamy, Shreya A., et al.
Publicado: (2021)

Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults
por: Bongiovanni, Tasce, et al.
Publicado: (2023)

Chronic Pruritus Responding to Dupilumab—A Case Series
por: Zhai, Lisa L., et al.
Publicado: (2019)

Current Evidence on Abuse and Misuse of Gabapentinoids
por: Hägg, Staffan, et al.
Publicado: (2020)

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab
por: Wachuku, Christopher I., et al.
Publicado: (2023)

Considerations When Using Gabapentinoids to Treat Trigeminal Neuralgia: A Review
por: De Stefano, Gianfranco, et al.
Publicado: (2023)

Evaluation, management and future perspectives of anal pruritus: a narrative review
por: Jakubauskas, Matas, et al.
Publicado: (2023)

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Risk of respiratory depression with opioids and concomitant gabapentinoids
por: Savelloni, Julie, et al.
Publicado: (2017)

A snapshot on the usage pattern of gabapentinoids in Oman
por: Badi, Abdulaziz Said Al, et al.
Publicado: (2022)

Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012)

Fatalities associated with gabapentinoids in England (2004–2020)
por: Kalk, Nicola J., et al.
Publicado: (2022)

The importance of cache domains in α(2)δ proteins and the basis for their gabapentinoid selectivity
por: Page, Karen M, et al.
Publicado: (2023)

Have We Just Scratched the Surface? A Narrative Review of Uremic Pruritus in 2020
por: Martin, Claire E., et al.
Publicado: (2020)

The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
por: Tang, Hui, et al.
Publicado: (2023)

Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]
Publicado: (2018)

Opioid and gabapentinoid prescriptions in England from 2015 to 2020
por: Xia, Yixue, et al.
Publicado: (2022)

Chronic Intractable Pruritus in Chronic Kidney Disease Patients: Prevalence, Impact, and Management Challenges — A Narrative Review
por: Świerczyńska, Karolina, et al.
Publicado: (2021)

Pruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative Review
por: Field, Halle, et al.
Publicado: (2016)

Gabapentinoid Prescribing Practices at a Large Academic Medical Center
por: Huang, Linda L., et al.
Publicado: (2023)

Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence
por: Chen, Eric Y., et al.
Publicado: (2021)

The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials
por: Meaadi, Jawza, et al.
Publicado: (2023)

Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Mechanisms of the gabapentinoids and α (2) δ‐1 calcium channel subunit in neuropathic pain
por: Patel, Ryan, et al.
Publicado: (2016)

Pruritus Ani
por: Song, Seok-Gyu, et al.
Publicado: (2011)

Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
por: Zhao, Danni, et al.
Publicado: (2022)

Nuts and Older Adults’ Health: A Narrative Review
por: Tan, Sze-Yen, et al.
Publicado: (2021)

Nalfurafine hydrochloride to treat pruritus: a review
por: Inui, Shigeki
Publicado: (2015)

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
por: Tambon, Marine, et al.
Publicado: (2021)

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: McAnally, Heath B., et al.
Publicado: (2021)

Narrative Review of Low-Intake Dehydration in Older Adults
por: Beck, Anne Marie, et al.
Publicado: (2021)

Pruritus of the Perineum
Publicado: (1924)

Mediators of Pruritus in Psoriasis
por: Reich, Adam, et al.
Publicado: (2007)

Mirogabalin, a selective gabapentinoid for managing neuropathic pain—A curtain raiser
por: Nair, Abhijit
Publicado: (2022)

Effectiveness and Adverse Events of Gabapentinoids as Analgesics for Patients with Burn Injuries: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
por: Chiang, Liang-Jui, et al.
Publicado: (2023)

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
por: Fonseca, Francina, et al.
Publicado: (2021)

Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study
por: Chan, Adrienne Y. L., et al.
Publicado: (2023)

Post-Burn Pruritus
por: Chung, Bo Young, et al.
Publicado: (2020)

Chloroquine-induced Pruritus
por: Aghahowa, S. E., et al.
Publicado: (2010)

Self-reported generalised pruritus among community-dwelling older adults in Malaysia
por: Yong, Shin Shen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7fehjksmrq07o99t1aqlt1j37c